Because optic nerve damage is a sign of glaucoma, baseline documentation of the optic nerve in all patients for later comparison is important. David M. Brown, MD, explains in this video blog.
The high cost of prescription medications can often prevent patient compliance. In this video blog, David M. Brown, MD, offers advice for prescribing drugs to cost-conscious patients.
In this video commentary, Dr. David Brown shares tips for using SD-OCT imaging in the perioperative period of cataract surgery to boost surgical success and patient satisfaction.
Dr. Jeffrey Lieberman discusses the ethics of disclosing or selling clinician prescribing data to private entities such as drug manufacturers.
Paul G. Auwaerter, MD, describes a case of facial cellulitis that would not get better and the observation that finally solved the mystery.
Dr. Roger Steinert offers his insights on the recent European Society of Cataract & Refractive Surgeons meeting. What are the anticipated latest advances and developments?
CMS Administrator Donald M. Berwick, MD, MPP, and Richard J. Gilfillan, MD, Acting Director, Center for Medicare and Medicaid Innovation, discuss the final ACO rules and how they will affect doctors.
Dr. Steve Charles takes you on a whirlwind tour of the latest developments in vitreoretinal surgery presented at AAO this year.
ROP was a hot topic at this year's AAO. Dr. Monte Mills reviews key data on the use of bevacizumab for this significant complication of prematurity.
Experts in glaucoma discuss news from AAO that could change clinical practice.